Get started
Author

Jamile Almeida Silva

Observed names: J. Almeida-Silva, Jamile Almeida-Silva
OpenAlex ID: A5000413381
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
2021 · Thomas Powles, Tibor Csőszi, et al. · The Lancet Oncology · 642
Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic response and PSMA imaging correlates.
2022 · Diogo Assed Bastos, Rafael Coelho, et al. · Journal of Clinical Oncology · 6
Clinical Characteristics and Treatment Outcomes of Patients With Advanced Germ Cell Tumor Treated at a Tertiary Cancer Center in Brazil
2019 · Vitor Fiorin Vasconcellos, Diogo Assed Bastos, et al. · Journal of Global Oncology · 5
High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil
2024 · Gabriel Berlingieri Polho, Mateus Trinconi Cunha, et al. · Clinical Genitourinary Cancer · 3
Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources
2025 · Diana del Cisne Pineda, Gabriel Berlingieri Polho, et al. · JCO Global Oncology · 1
Neoadjuvant androgen receptor pathway inhibition for patients with high-risk localized prostate cancer: 5-year survival update and PSMA PET correlatives of the randomized NeoPRO trial.
2026 · Gabriel Berlingieri Polho, Gabriella Soares, et al. · Journal of Clinical Oncology
PDF
Prospective analysis of AR-V7 expression in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) sequentially treated with docetaxel and enzalutamide.
2025 · Diogo Assed Bastos, Luiza Primo, et al. · Journal of Clinical Oncology
High-dose chemotherapy with autologous stem cell transplant (HDCT) for patients (pts) with advanced germ-cell tumors (aGCT): Real-world evidence from a tertiary cancer center in Brazil.
2023 · Gabriel Berlingieri Polho, Mateus Trinconi Cunha, et al. · Journal of Clinical Oncology
PDF
Rare intrascrotal tumors in a tertiary cancer center: A retrospective case series.
2022 · Mateus Trinconi Cunha, Camila Cardoso, et al. · Journal of Clinical Oncology
Paratesticular and Non-germ Cell Testicular Tumors in a Tertiary Cancer Center: a Retrospective Series
2021 · Mateus Trinconi Cunha, Camila Abdalla Antunes Cardoso, et al. · Brazilian Journal of Oncology
Male breast cancer: Epidemiological evaluation and clinical outcomes.
2020 · Edla Renata Cavalcante, Katia Regina Marchetti, et al. · Journal of Clinical Oncology
Performance status (PS) in advanced germ cell tumors (aGCT): Clinical and prognostic value of an underreported important variable.
2018 · Vitor Fiorin de Vasconcellos, Diogo Assed Bastos, et al. · Journal of Clinical Oncology
Desajustes Macroeconômicos E Inflexão Na Condução Da Política Fiscal Brasileira
2018 · Jamile Almeida Silva · Anais dos Seminários de Iniciação Científica
Clinical characteristics and treatment outcomes of patients (pts) with advanced germ cell tumor (aGCT) treated at a tertiary cancer center in Brazil.
2018 · Vitor Fiorin de Vasconcellos, Diogo Assed Bastos, et al. · Journal of Clinical Oncology
Resposta Sustentada Com Denosumabe Em Tumores De Células Gigantes Localmente Avançado
2017 · Luana Guimarães de Sousa, Julia De Stefani Cassiano, et al. · Brazilian Journal of Oncology
2373 Treatment outcomes of patients with metastatic anal cancer according to HIV status
2015 · C.M. Venchiarutti Moniz, J. Almeida-Silva, et al. · European Journal of Cancer
Works count: 16
Citation count: 657
H-index: 3
I10-index: 1
Year
Topic
Type